glp 1 drugs and parkinson's disease Repurposing GLP-1 Receptor Agonists for Disease: Current Evidence Future Opportunities | Pharmaceutical Medicine GLP-1R agonists approved by the
Description
By distribution channel, the online pharmacies segment is expected to expand at the fastest CAGR during 2025-2034
How widespread is GLP-1 usage in the U.S
Gold SL, Rabinowitz LG, Manning L, Keefer L, Rivera-Carrero W, Stanley S, et al
The median time elapsed from the earliest patent filing date within a given product to the expiration date of the last-to-expire patent or exclusivity on that product was 31.9 years (IQR: 29.9-36.6)
doi: 10.1007/s10557-025-07670-9, 56
